R. Kluger et al., CROSS-LINKING HEMOGLOBIN BY DESIGN - LESSONS FROM USING MOLECULAR CLAMPS, Artificial cells, blood substitutes, and immobilization biotechnology, 22(3), 1994, pp. 415-428
The development of a red cell substitute by chemical modification of h
emoglobin has been approached as a systematic, iterative process. Acyl
phosphate methyl esters were designed as anionic electrophiles to per
mit selective acylation of amino groups in the cationic site of hemogl
obin which binds polyanions. Kinetic studies with systematically subst
ituted acyl phosphates and amines show that the reaction is controlled
by a reversible addition step followed by an irreversible elimination
step. Acyl phosphate methyl esters which are derivatives of rigid dic
arboxylic acids introduce cross-links in human hemoglobin between amin
o groups in the beta subunits (epsilon-NH2-Lys-82, alpha-NH2-Val-1) an
d permit correlation of oxygen binding properties with cross-link stru
cture. The data suggest that the cross-link maintains cooperativity wh
ile reducing overall oxygen affinity by lowering the affinity of the R
form for oxygen rather than by perturbing the R,T equilibrium of nati
ve hemoglobin. Materials produced from deoxyhemoglobin with a cross-li
nk between positions 1 and 82 of the two beta units have appropriate o
xygen affinity for red cell substitutes. The use of a trifunctional cr
oss-linker, trimesyl tris(methyl phosphate) selectively produces hemog
lobin with the desired 1-82 connection in good yield. The reagent is r
eadily prepared and the properties of this chemically modified hemoglo
bin are suitable for trial as a red cell substitute, closely resemblin
g those of optimized materials produced by recombinant technology. Fur
ther work is producing new chemicals and providing structural informat
ion.